Recent Top Picks | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Recent Top Picks

Date Signal Company Expert Opinion Price
2017-05-12 TOP PICK Alphamin-Resources-Corp
AFM-X
Rick Rule

The largest and highest grade tin deposit in the world. The median grade in this deposit is 5X the average mine grade. A superbly great deposit. The bad news is that it is in the Congo, and it is in a bad part of the Congo. Thinks this will go into production.

Price:
$0.390
Subject:
RESOURCE
Bias:
UNKNOWN
Owned:
Yes
2017-05-12 TOP PICK Alon-USA-Partners
ALDW-N
Chris Damas

This only has one refinery, but it is smack dab in the Permian Basin, the epicenter of growing production. Drilling rigs use diesel, so they are getting great prices. His target on this is $15. Dividend yield of 7%. (Analysts’ price target is $11.50.)

Price:
$11.330
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
UNKNOWN
Owned:
Yes
2017-05-12 TOP PICK Cornerstone-Capital-Resources.
CGP-X
Rick Rule

They’ve made a tremendous discovery with a company called Falgold in Ecuador, which owns 85% of the deposit. He thinks they would like to own 100% of the deposit, and the way they do that is to buy Cornerstone.

Price:
$0.495
Subject:
RESOURCE
Bias:
UNKNOWN
Owned:
Yes
2017-05-12 TOP PICK PBF-Energy
PBF-N
Chris Damas

A midsized refiner. He likes contrarian situations. People think there is too much gasoline. Tesla’s are going to be all over the place, self driving cars, etc. Why do we need oil? Most of the world is not that advanced. This company has almost doubled the amount of refinery throughput. They have 5 refineries after buying 2 from Exxon on the cheap, so they now have Tidewater access. Gasoline has gone up 300 million barrels of consumption in the last 3 years. The stock is probably worth $30. Dividend yield of 5.3%. (Analysts’ price target is $25.)

Price:
$22.180
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
UNKNOWN
Owned:
Yes
2017-05-12 TOP PICK Sheffield-Resources
SFX-AX
Rick Rule

(Australian stock exchange.) A mineral sands deposit producing stuff like titanium, chromium. A business that isn’t particularly well known in Canada, but generates an awful lot of cash when it is done right.

Price:
$0.000
Subject:
RESOURCE
Bias:
UNKNOWN
Owned:
Yes
2017-05-12 TOP PICK Twitter--Inc
TWTR-N
Chris Damas

This has some bad actors on it, but everybody knows it. They only charge $20 a year for a premium service that generates $3.6 billion in revenues. (Analysts’ price target is $15.)

Price:
$18.610
Subject:
Cannabis, Agriculture & Fertilizer
Bias:
UNKNOWN
Owned:
No
2017-05-11 TOP PICK iShares-Nasdaq-BioTech-ETF
IBB-Q
Hap (Robert) Sneddon FCSI

All biotech shares are pretty volatile, and there have been some pretty big moves in the last couple of months. He expects this to run up and hit the high of $380, and then run past that. This is a generational change. Good space to be in long-term. 10 years and you should be very happy.

Price:
$291.570
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK Questrade-Russell-1000-Equal-Weight-US-Health-Care-tra
QRH-T
John Hood

He really likes this one.  They cut their fees 50% so this is only 25 basis points.  They took 80 mid cap health care stocks.  He quite likes the structure.

Price:
$21.220
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
Yes
2017-05-11 TOP PICK Sierra-Wireless
SW-T
Hap (Robert) Sneddon FCSI

He likes the space “the Internet of things” that this is in. This has about 38% of the business in Canada and he thinks it is going to keep growing. It is in the right sector, between the pro-growth and the defensive. They just had a fantastic quarter and caught the street off guard. Sees this having a double from here. The next resistance is around $46, and he thinks it is taking out the $58 at some point. (Analysts’ price target is $29.50.)

Price:
$38.130
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK SPDR-Energy-ETF
XLE-N
John Hood

US energy index ETF.  It is so out of favour now, but there are a number of things that are lining up.  The Saudis want to get the price of oil up because they want to sell off an asset.  He is buying it because it is out of favour and he prefers it to the Canadian energy sector.

Price:
$67.980
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
Yes
2017-05-11 TOP PICK iShares-S-and-P-TSX-Cap.-Cons.-St.
XST-T
Hap (Robert) Sneddon FCSI

Just had a nice little break out. If you don’t like the ETF, you could look at their top holdings. Good mix long-term. Thinks that a year from now you will be quite happy with this.

Price:
$56.610
Subject:
TECHNICAL ANALYSIS & MACRO STRATEGY
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-11 TOP PICK BMO-Europe-High-Dividend-Covered-Call-Hedged-to-CAD-ET
ZWE-T
John Hood

A play on Europe where he does not have to worry about the Euro or the Pound.

Price:
$22.540
Subject:
OPTIONS & ETFs
Bias:
BULLISH on US MARKET
Owned:
No
2017-05-10 TOP PICK Arris-International-Plc
ARRS-Q
John Burke

This makes Wi-Fi routers, which are in greater and greater demand. Their biggest customer is AT&T (T-N), but they also supply Amazon (AMZN-Q). (Analysts’ price target is $33.50.)

Price:
$28.190
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Astrazeneca-P-L-C
AZN-N
Paul Macdonald

A diversified pharmaceutical, sort of shifting their business away from traditional fields. They are in decline right now on revenues. You want to be holding this along with Merck and Bristol-Myers. They have a very key study coming out, taking an immuno oncology drug and combining it with another immuno oncology drug. That is going to be a very key catalyst. Dividend yield of 4.5%. (Analysts’ price target is $34.)

Price:
$31.040
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
2017-05-10 TOP PICK Celgene-Corp
CELG-Q
Paul Macdonald

They are able to double revenues between now and 2020 without a lot of pipeline success. The PEG ratio at .8, is not painful for a lot of their growth. Great financial metrics and you are not paying a lot for it. Some recent volatility presents a decent entry point. (Analysts’ price target is $146.)

Price:
$119.680
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
Showing 31 to 45 of 23,886 entries
<< < 1 2 3 4 5 > >>